Vaxcyte, Inc. PCVX Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Vaxcyte, Inc.’s reported figures.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s enterprise value?
- Vaxcyte, Inc. (PCVX) reported enterprise value of $8.22B in Q1 2026.
- How has Vaxcyte, Inc.'s enterprise value changed year-over-year?
- Vaxcyte, Inc.'s enterprise value increased by 78.6% year-over-year, from $4.6B to $8.22B.
- What is the long-term trend for Vaxcyte, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s enterprise value has grown at a 43.8% compound annual growth rate (CAGR), from $974.42M to $5.98B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.